ImmunoPrecise Antibodies (IPA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist

0.400
-0.020-4.76%

Close Dec 20 16:00 ET

0.410
+0.010+2.42%

Post 16:55 ET

12.43MMarket Cap-0.54P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IPA to Present at The Microcap Conference 2025
AccesswireDec 19 10:15 ET
Benchmark Co. Maintains ImmunoPrecise Antibodies(IPA.US) With Buy Rating, Maintains Target Price $3
Moomoo NewsDec 16 07:31 ET · Ratings
Analysts Offer Insights on Healthcare Companies: ImmunoPrecise Antibodies (IPA), Neurocrine (NBIX) and Becton Dickinson (BDX)
TipRanksDec 16 07:20 ET · Ratings
HC Wainwright & Co. Maintains Buy on ImmunoPrecise Antibodies, Lowers Price Target to $7
BenzingaDec 11 12:58 ET · Ratings
Express News | Immunoprecise Antibodies Ltd. : H.c. Wainwright Cuts Target Price to $7 From $9
ReutersDec 11 10:05 ET
Earnings Call Summary | ImmunoPrecise Antibodies(IPA.US) Q2 2025 Earnings Conference
moomoo AIDec 10 17:42 ET · Conference Call

Comments

Jaguar8

Dec 10 07:59

NEWS

$ImmunoPrecise Antibodies (IPA.US)$
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025
Tuesday, 10th December at 8:30 am
Delivers $6.1 Million Q2 Revenue and Announces Strategic Plan to Reshape Biotech and AI-Driven Drug Discovery
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today reported financial results for the second quarter ("Q2...

Casper2k

Nov 24 15:00

$ImmunoPrecise Antibodies (IPA.US)$ any clue if this thing is going to take off???

purp73

Nov 14 09:04

The price is so cheap now.

$ImmunoPrecise Antibodies (IPA.US)$ The lowest price is at 0.350. I think It looks ready to climb up soon.

Clintzilla

Nov 13 14:00

$ImmunoPrecise Antibodies (IPA.US)$ really needs to be a beer ticker.. FML

Teddy123

Nov 13 08:38

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies

$ImmunoPrecise Antibodies (IPA.US)$
VICTORIA, British Columbia--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), a leader in AI-driven medical innovation, is proud to announce a significant breakthrough in its primary cancer research initiatives. This accomplishment not only highlights IPA’s cutting-edge discovery and AI capabilities, but it...

Heat List

Overall

No Data